Categories
Pharmaceutical

Rising Focus On Healthcare Propel Demand Of Ventricular Restoration Systems Market

In its recently added report by Fact.MR has provided unique insights about Ventricular Restoration Systems Market for the given period. One of the main objectives of this report is to categorize the various dynamics of the market and to offer the latest updates such as mergers and acquisitions, various technological developments, new entrants in the market, which make an impact on different segments.

The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with a detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.

REQUEST A FREE DEMO OF REPORT- https://www.factmr.com/connectus/sample?flag=B&rep_id=5288

Research Coverage

This report segments the functional proteins market based on type, source, form, application and region. In terms of insights, this research report focuses on various levels of analyses—competitive landscape, pricing insights, end-use analysis, and company profiles—which together comprise and discuss the basic views on the emerging & high-growth segments of the functional proteins market, high-growth regions, countries, industry trends, drivers, restraints, opportunities, and challenges.

Critical insights enclosed in the report:

    • In-depth assessment of the leading market players in the Ventricular Restoration Systems market
    • The regional analysis of the different market segments and sub-segments
    • Recent mergers, acquisitions, collaborations, partnerships, and R&D activities.
  • SWOT analysis of the prominent players in the Ventricular Restoration Systems market
  • Y-o-Y revenue growth of the Ventricular Restoration Systems market during the forecast period

Ventricular Restoration Systems Market: Key players

Some of the players identified in the Ventricular restoration systems Market include:

  • Abott
  • Bioventrix Inc.
  • Xeltis AG
  • Neochord Inc.
  • CryoLife Inc.
  • Edwards Lifesciences Corp.
  • CardioKinetics Inc.

Ventricular Restoration Systems Market: Segmentation

Tentatively, the global Ventricular restoration systems Market market has been segmented on the basis of application and end-user.

Based on Application, the global Ventricular restoration systems Market market is segmented as:

  • Percutaneous ventricular restoration
  • Surgical ventricular restoration

Based on distribution channel, the global Ventricular restoration systems Market market is segmented as:

  • Specialty clinics
  • Hospitals
  • Ambulatory surgical centers

Ventricular Restoration Systems Market: Drivers

The rise in no. of cardiac cases around the world is the major factor driving the growth of ventricular restoration systems market.

The rising focus on healthcare across various region is another factor that is estimated to propel the growth of the ventricular restoration systems market.

In addition, rising growth in medical tourism in certain developing countries will also contribute towards the growth of the ventricular restoration systems market.

Increasing demand for innovative products and constant R&D activities carried out by the manufacturers to improve the technological aspect in these medical devices will also boost the growth of the ventricular restoration systems market.

The accessibility to different medical coverage for the repayment of cardiovascular medical procedures will also contribute towards the growth of the ventricular restoration systems market.

Reasons to buy this report

  • To get a comprehensive overview of the Ventricular Restoration Systems market
    • To gain wide-ranging information about the top players in this industry, their product portfolio details, and the key strategies adopted by them
    • To gain insights about the major countries/regions, in which the Ventricular Restoration Systems market is flourishing

REQUEST FOR CUSTOMIZED REPORT – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5288

Ventricular Restoration Systems Market: Overview

Based on application, the percutaneous ventricular system is expected to experiences considerable growth during the forecast period owing to the minimization of the risk of a more invasive method.

In the end user segment, hospitals will continue to hold the largest share in the ventricular restoration systems market. The no. of cardiac surgeries carried out in the hospital is expected to contribute towards the continued growth of this segment. The effective in-patient and out-patient services may account for a higher market share.

Ventricular Restoration Systems Market: Regional-Wise OutlookGeographically, the Ventricular restoration systems Market market is segmented into seven regions viz. South Asia, East Asia, Europe, Latin America, North America, Oceania and Middle East and Africa.North America is expected to hold the largest market share in the ventricular restoration systems market. This can be attributed towards high demand and adoption of the ventricular restoration systems.

Moreover, this well-established healthcare system along with skilled professional will also serve as one of the major factors leading to the dominance of this region in the global ventricular restoration systems market.

The large R&D investments made by key players in this region to cater to the needs of the population also contributes towards the growth of the ventricular restoration systems market in this region.

Europe is expected to hold the 2nd largest market share owing to rising cardiovascular cases in this region. However, East Asia and South Asia is expected to experience fastest growth in the ventricular restoration systems market.

The exponentially growing medical device industry in this region will lead to considerable growth of the market in this region. In addition, medical tourism in countries like India will further propel the growth of the ventricular restoration systems market in this region.

Why Purchase From Fact.MR?

  • Customized market reports as per the clients’ requirement
  • Rich experience in curating market reports for clients from different industrial domains
  • Round the clock customer service for clients in different time zones
  • Over 300+ queries addressed every day
  • Catering to over 700+ clients each year

Explore Fact.MR’s Coverage on the Healthcare Domain: 

Leukocyte Count Testing Market – According to the latest research by Fact.MR, the leukocyte count testing market is set to witness exponential growth with over 7%-8% CAGR during 2021-2031. Increasing bacterial infection with the growing adoption of point of care devices will witness a promising growth outlook for leukocyte count testing in the long run.

At-Home Celiac Testing Market – According to the Latest Research by the Fact.MR The Celiac Testing market is set to gain growth in the forecast period 2021-2031 at a CAGR of 8.0%. The Reason for the growth is The increase in prevalence of Celiac disease globally.

Polysaccharide Hemostatic System Market – According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness a XX% growth during the year 2021-2031.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Transesophageal Echocardiography Demand Grows as CVD Deaths Surpasses 15 million, Scrutinized in the New Analysis

Fact.MR – A Market Research and Competitive Intelligence Provider: As per the insights by Fact.MR, the global market for transesophageal echocardiography is projected to grow at a steady CAGR over the assessment period 2021-2031.

Rising prevalence of cardiac and coronary heart diseases is a primary factor supporting the growth of the transesophageal echocardiography market. The market also will gain momentum on account of the increasing number of medical imaging procedures conducted for heart disease diagnosis and treatment.

Also, transesophageal echocardiography has currently emerged as a preferred choice in comparison to traditional systems. It provides high quality images, which, in turn will create a conducive environment for rising adoption of the method.

Besides these, growing healthcare spending coupled with increasing technological advancements are likely to boost the market growth over the forthcoming years.

Effective integration of 3-dimensional (3D) and 4-dimensional (4D) imaging technologies is intended at assisting clinicians to regulate high-grade treatment.  These developments will spur sales prospects of the market over the assessment period.

Request a report sample to gain comprehensive insights at

https://www.factmr.com/connectus/sample?flag=B&rep_id=5285

In the coming years, market will witness increasing investments in research and development activities as manufacturers seek to introduce advanced transesophageal echocardiography products.

Regionally, North America will remain a highly lucrative market due to the increasing adoption of new technologies, increasing healthcare spending, and rising awareness regarding the early diagnosis and treatment of cardiac diseases.

Apart from this, increasing patient pool coupled with rapid healthcare advancements will embolden future growth prospects.

Key Takeaways from Transesophageal Echocardiography Market Survey

  • Driven by advanced healthcare spending, the North America market is anticipated to expand at an impressive CAGR over the forecast period 2021-2031.
  • Europe market for transesophageal echocardiography is forecast to emerge as a lucrative pocket, exhibiting a healthy CAGR over the forthcoming years.
  • Asia Pacific market is likely to register fastest growth owing to increasing incidence of heart diseases.
  • Due to increasing patient pool, India and China market are anticipated to gain significant pace over the assessment period.
  • Backed by increasing government policies, Brazil market for transesophageal echocardiography is projected to grow at a rapid pace between 2021 and 2031.

Key Drivers

  • Rising prevalence of cardiac and coronary heart diseases are driving the market growth.
  • Increasing number of medical surgical procedures are likely to boost the market growth.

Key Restraints

  • High cost associated with transesophageal echocardiography treatments is expected to hinder the market growth.
  • The availability of alternative imaging technologies may hamper the market sales.

To gain in-depth insights on Transesophageal Echocardiography Market, request customization at

https://www.factmr.com/connectus/sample?flag=RC&rep_id=5285

Competitive Landscape

Transesophageal echocardiography manufacturers are undertaking acquisitions and collaborations to increase market footprint.

For instance, in 2020, Spacelabs Healthcare, a global producer and designer of patient monitoring and diagnostic cardiology solutions, announced the acquisition of an innovative cloud platform developed by BoxView, LLC. This acquisition of patient and device reporting business strengthens spacelabs digital health portfolio.

In 2021, Hillrom announced the planned acquisition of Bardy Diagnostics, Inc, an innovator in digital health and a leading provider of ambulatory cardiac monitoring technologies.

Some of the leading players operating in the Transesophageal echocardiography market profiled by Fact.MR are:

GE Healthcare
Allengers
Philips Healthcare
Hill-Rom
AliveCor
NIHON KOHDEN
Applied Cardiac Systems
Spacelabs Healthcare
Schiller
AMEDTEC Medizintechnik Aue
Bionym (now Nymi)
CardioComm Solutions
ASPEL
CardioSecur
Cardiac Designs
Bionet
Beurer
Cardioline

More Valuable Insights on Transesophageal Echocardiography Market

Fact.MR, in its new report, offers an unbiased analysis of the global transesophageal echocardiography market, analyzing forecast statistics through 2021 and beyond. The survey reveals growth projections on transesophageal echocardiography market with detailed segmentation:

Based on product type the transesophageal echocardiography (TEE) market can be segmented as

  • Two-Dimensional (2D)TEE
  • Three-Dimensional (3D)TEE
  • Four-Dimensional (4D)TEE

Based on disease type the transesophageal echocardiography (TEE) market can be segmented as

  • Congenital Heart Disease
  • Heart Valve Disease
  • Coronary heart disease
  • Blood Vessel Disease
  • Others

Based on end user the transesophageal echocardiography (TEE) market can be segmented as

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Home Care Settings
  • Point of Care

Key Questions Covered in the Transesophageal Echocardiography Market Report 

  • The market survey also highlights projected sales growth for transesophageal echocardiography market between 2021 and 2031
  • The report offers insight into transesophageal echocardiography demand outlook for forecast period 2021-2031
  • Transesophageal echocardiography market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, collaborations or partnerships, and others
  • Transesophageal echocardiography market analysis identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry

Explore Fact.MR’s Coverage on the Healthcare Domain: 

Leukocyte Count Testing Market – According to the latest research by Fact.MR, the leukocyte count testing market is set to witness exponential growth with over 7%-8% CAGR during 2021-2031. Increasing bacterial infection with the growing adoption of point of care devices will witness a promising growth outlook for leukocyte count testing in the long run.

At-Home Celiac Testing Market – According to the Latest Research by the Fact.MR The Celiac Testing market is set to gain growth in the forecast period 2021-2031 at a CAGR of 8.0%. The Reason for the growth is The increase in prevalence of Celiac disease globally.

Polysaccharide Hemostatic System Market – According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness a XX% growth during the year 2021-2031.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Global Th17 Driven Disease Market Growth banking on Faster Regulatory Approvals for Key Drug Candidates

Award winning market research company Fact.MR’s ongoing study on the Th17 driven disease treatment market opines that the market is expected to embark on an optimistic growth path through 2021, as the global healthcare industry emerges from the recessionary impacts of the novel coronavirus pandemic.

The market is expected to enjoy robust growth over the coming years. Based on Indication Th17 Driven disease treatment market is classified into Psoriasis, Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease and Asthma. By the Drug type, Gentamicin, Azathioprine, Calcipotriol, Trolamine salicylate, Histamine and Capsaicin. By distribution channel, hospital pharmacies, is expected to dominate Th17 driven disease treatment market.

North America accounts for a significant revenue share, and is expected to dominate the Th17 driven disease treatment. This is attributed to the increasing prevalence of rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease and asthma. Countries like South Africa, Japan, Brazil, Germany and UK hold a significant market value share. Th17 driven disease treatment market in Asia Pacific is projected to expand at significant growth, driven by rapid regulatory approval for potential drug candidates. Rising government initiatives to increase awareness about the disease is stimulating growth of Th17 Driven disease treatment market.

Request Brochure at https://www.factmr.com/connectus/sample?flag=B&rep_id=5284

Key Takeaways from Fact.MR’s Th17 Driven Disease Market Study

  • By indication, psoriasis treatment is expected to capture a high market share, amid its rising prevalence
  • Demand for azathioprine is likely to soar, owing to widespread application in treating rheumatoid arthritis
  • By distribution channel, hospital pharmacies to remain the primary Th17 driven disease drug suppliers
  • US to experience high drug sales on the back of surging cases of inflammatory bowel disease
  • Surging eczema cases to bolster Th17 driven disease drug sales across the UK market
  • Robust healthcare infrastructure is accelerating inflammatory disease treatment research across Germany
  • India to experience heightened investments in drug development research, amid rising cases of colitis and Crohn’s disease

Th17 Driven Disease Market- Prominent Drivers

  • Fast tracking of regulatory approvals of key drug candidates is heightening Th17 driven disease market growth prospects
  • Availability of multiple treatment alternatives to significantly widen growth prospects
  • Presence of a robust global supply chain network to accelerate R&D for new drug candidates, stimulating growth

Th17 Driven Disease Market- Key Restraints

  • Prolonged durations of clinical trials and subsequent waiting list regarding regulatory approvals is restricting growth
  • Expensive nature of available drugs owing to limited supply is limiting proper sales prospects for the market

Request Customization – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5284 

Competitive Landscape

Prominent players in Th17 driven disease treatment market as profiled by Fact.MR’s report are AbbVie, Alexion Pharmaceuticals, Alder Biopharmaceuticals and Astellas Pharma. The aforementioned players are reliant on regulatory approvals for potential drug candidates. In addition, capacity expansion measures, including partnerships, collaborations and acquisitions are also relied upon.

Recently, in April 2021, AbbVie submitted regulatory applications for SKYRIZI® (risankizumab) for treating Psoriatic Arthritis to the US FDA and the European Medicines Agency (EMA). These submissions are supported by two phase 3 studies in patients with active psoriatic arthritis wherein the drug exhibited improved skin and joint symptoms and physical function.

With regard to acquisitions, UK pharmaceutical giant AstraZeneca announced in December 2020 that it intends to acquire Alexion Pharmaceuticals in order to broad base its scientific presence in immunology, and will also likely heighten the company’s portfolio of Th17 driven diseases treatment in the years to come.

More Insights on the Th17 Driven Disease Market

Fact.MR, in its new offering, brings to fore an unbiased analysis of the global Th17 driven disease market, presenting historical demand data (2016-2020) and forecast statistics for the period, 2021-2031. The study divulges compelling insights on the market based on indication (psoriasis, rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease and asthma), drug (gentamicin, azathioprine, calcipotriol, trolamine salicylate, histamine and capsaicin) and distribution channel (hospital pharmacies, pharmacies and online pharmacies) across eight major regions (North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, China, Japan and Middle East & Africa).

Explore Fact.MR’s Coverage on the Healthcare Domain: 

Leukocyte Count Testing Market – According to the latest research by Fact.MR, the leukocyte count testing market is set to witness exponential growth with over 7%-8% CAGR during 2021-2031. Increasing bacterial infection with the growing adoption of point of care devices will witness a promising growth outlook for leukocyte count testing in the long run.

At-Home Celiac Testing Market – According to the Latest Research by the Fact.MR The Celiac Testing market is set to gain growth in the forecast period 2021-2031 at a CAGR of 8.0%. The Reason for the growth is The increase in prevalence of Celiac disease globally.

Polysaccharide Hemostatic System Market – According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness a XX% growth during the year 2021-2031.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Subcutaneous Biologics Market Growth Spurred by Accelerating Cancer and Diabetes Treatment Initiatives: Fact.MR

Award winning market research company Fact.MR is currently pursuing a study on the global subcutaneous biologics market. Growth prospects for 2021 and beyond appear significant, with healthcare providers resuming R&D projects which has suffered a setback amidst the coronavirus pandemic crisis.

As per Fact.MR’s analysis, the subcutaneous biologics market stands to gain the maximum from cancer and diabetes drugs development. While the International Diabetes Federation estimates that the number of diabetics shall increase to 578 million people by 2030 from the existing 463 million, the number of cancer patients are likely to rise by over 80% across low-income countries; and 40% in high-income countries (WHO).

Consequently, government entities are fast tracking drug candidate approvals so as to offset this increasing burden. In June 2020, for instance, the US Food & Drug Administration approved Genentech Inc.’s Phesgo (pertuzumab, trastuzumab and hyaluronidase- zzxf) for injection under the skin to treat adult patients with HER-2 positive breast cancer. Likewise, in March 2020, Celltrion announced the launch of its subcutaneous Remsima (infliximab) formulation, which is the only subcutaneous formulation of the Remicade biosimilar for treating rheumatoid arthritis patients.

Request Brochure at https://www.factmr.com/connectus/sample?flag=B&rep_id=5283

The global subcutaneous biologics market is classified based indication, delivery system, distribution channel and region.

Based on the indication, the subcutaneous biologics market is segmented into the following:

  • Cancer
  • Crohn’s disease
  • Cardiovascular disorders
  • Diabetes
  • Multiple sclerosis
  • Psoriasis
  • Rheumatoid Arthritis
  • Metabolic disorders
  • Growth hormone deficiency
  • Others

Based on the delivery system, the subcutaneous biologics market is segmented into the following:

  • Syringe
  • Wearable injector
  • Automatic injector
  • Implants
  • Pen injectors
  • Others

Based on the distribution channel, the subcutaneous biologics market is segmented into the following:

  • Hospital pharmacies
  • Retail pharmacies
  • Drug stores
  • Online pharmacies

Subcutaneous Biologics Market- Prominent Drivers

  • Expanding geriatric population pool and subsequent increase in chronic ailments prevalence to drive future subcutaneous biologics sales
  • Key manufacturers are targeting the Asia-Pacific region for future growth, attributed to an exponential population surge
  • Increased research & development funding along with favorable government policies are accelerating subcutaneous biologics research

Subcutaneous Biologics Market- Key Restraints

  • Documented allergic reactions post-biologics consumption is likely to hinder uptake across key regions
  • Prolonged waiting durations with respect to regulatory approvals is expected to slow subcutaneous biologics adoption

Discover more about the subcutaneous biologics market on – https://www.factmr.com/report/5283/subcutaneous-biologics-market

Key Takeaways from Fact.MR’s Subcutaneous Biologics Market Study

  • Subcutaneous biologic drug development for cancers is expected to acquire massive momentum
  • By delivery system, pen injectors are likely to become the preferred administration route
  • Rising popularity of home diagnostics compelling high subcutaneous biologics sales through retail pharmacies
  • Increasing cancer and diabetes incidence stimulating subcutaneous biologics development across the US
  • UK to experience high growth amid increasing research funding for psoriasis treatment
  • Conducive government policies to promote biologics and biosimilars development to heighten Germany and France’s growth prospects
  • India and China to collectively cement their dominance across the Asian market

Competitive Landscape

Prominent subcutaneous biologics market players profiled by Fact.MR include Abbott Laboratories, Pfizer Inc., Genentech Inc., Novartis AG, Biogen Idec, AbbVie Inc, F. Hoffmann-La Roche AG, Genmab A/S, Bristol-Myers Squibb, Eisai Inc., Takeda Pharmaceuticals Ltd., Alnylam Pharmaceuticals, Bayer AG, GlaxoSmithKline, Sanofi SA and Boston Pharmaceuticals among others.

The aforementioned market players rely on regulatory approvals of their product lines in order to enhance their penetration into the market. In March 2021, Genentech’s Actemra became the first biologic therapy approved by the US FDA for slowing the rate of decline in pulmonary function in adults suffering from systemic sclerosis-associated interstitial lung disease.

Likewise, in August 2020, the FDA approved Genmab A/S’s Kesimpta® (ofatumumab) injection for subcutaneous use to treat relapsing forms of multiple sclerosis (RMS) in adults, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. Kesimpta is the first B-cell therapy which is suitable for self-administration.

More Insights on the Subcutaneous Biologics Market

Fact.MR, in its new offering, brings to fore an unbiased analysis of the global subcutaneous biologics market, presenting historical demand data (2016-2020) and forecast statistics for the period, 2021-2031. The study divulges compelling insights on the market based on indication (cancer, Crohn’s disease, cardiovascular disorders, diabetes, multiple sclerosis, psoriasis, rheumatoid arthritis, metabolic disorders, growth hormone deficiency and others), delivery system (syringe, wearable injector, automatic injector, implants, pen injectors and others) and distribution channel (hospital pharmacies, retail pharmacies, online pharmacies and drug stores) across seven major regions (North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa).

Explore Fact.MR’s Coverage on the Healthcare Domain: 

Leukocyte Count Testing Market – According to the latest research by Fact.MR, the leukocyte count testing market is set to witness exponential growth with over 7%-8% CAGR during 2021-2031. Increasing bacterial infection with the growing adoption of point of care devices will witness a promising growth outlook for leukocyte count testing in the long run.

At-Home Celiac Testing Market – According to the Latest Research by the Fact.MR The Celiac Testing market is set to gain growth in the forecast period 2021-2031 at a CAGR of 8.0%. The Reason for the growth is The increase in prevalence of Celiac disease globally.

Polysaccharide Hemostatic System Market – According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness a XX% growth during the year 2021-2031.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

External Beam Radiotherapy Segment Is Expected To Register Upsurge Growth In The Global Single Dose Radiotherapy Market

The latest research report published by Fact.MR on the Single Dose Radiotherapy Market is intended to offer reliable data on various key factors shaping the growth curve of the market. This report works as a rich source of information for key entities such as policy makers, end-use industries, investors, and opinion leaders. The research report published by Fact.MR on the Single Dose Radiotherapy Market provides a detailed overview of the demands and consumptions of various products/services associated with the growth dynamics of the market during the forecast period 2020 to 2030. The in-depth market estimation of various opportunities in the segments is expressed in volumes and revenues. The insights and analytics on the Single Dose Radiotherapy Market span several pages. These are covered in numerous sections, including, drivers and restraints, challenges and opportunities, regional segmentation and opportunity assessment, end-use/application prospects analysis, and competitive landscape assessment.

In addition to understanding the demand patterns of various end users, the report on the Single Dose Radiotherapy Market also enumerates trends expected to attract investments by other various associated industries. The Single Dose Radiotherapy Market report offers detailed assessments and quantitative evaluations that shed light on numerous key aspects that have shaped its evolution over the historical period. In coming years, some of the key aspects that will shape the growth prospects during the forecast period are objectively covered in the study. The following insights and evaluations are worth knowing for any market participant, helping them in ascertaining the prevailing dynamics and the future trajectories of the Single Dose Radiotherapy Market. They are a part of the estimations of the opportunities in various segments.

Request for Brochure – https://www.factmr.com/connectus/sample?flag=B&rep_id=5282

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Single Dose Radiotherapy Market: Segmentation

The international single dose radiotherapy treatment market is segmented based on indication, therapy, end user and region.

By indication, the global single dose radiotherapy market is segmented as:

  • Breast Cancer
  • Prostate Cancer
  • Others

By therapy, the global single dose radiotherapy market is segmented as:

  • External Beam Radiotherapy
  • Internal Beam Radiotherapy/Brachytherapy

By end users, the global single dose radiotherapy market is segmented as:

  • Multi-specialty Hospital
  • Cancer Clinics

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Get Access To Research Customization – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5282

Single Dose Radiotherapy Market: Key Players

The key players for the global single dose radiotherapy market Varian Medical Systems, Accuray, Elekta, Ion Beam Applications, IsoRay Medical, ViewRay, Hitachi, Provision Healthcare, Mevion Medical Systems and Panacea Medical Technologies among others.

After reading the market report, readers get insight into: 

  • Major drivers and restraining factors, opportunities and challenges, and the competitive landscape
  • New, promising avenues in key regions
  • New revenue streams for all players in emerging markets
  • Focus and changing role of various regulatory agencies in bolstering new opportunities in various regions
  • Demand and uptake patterns in key industries of the Single Dose Radiotherapy Market
  • New research and development projects in new technologies in key regional markets
  • Changing revenue share and size of key product segments during the forecast period 2020 to 2030
  • Technologies and business models with disruptive potential

Some important questions that the Single Dose Radiotherapy Market report tries to answer exhaustively are: 

  • Important strategic moves by various players in the global market in recent years with respect to product launches, deals and tie-ups, and mergers and acquisitions, and divestment of shares
  • Which strategies will enable top players in the Single Dose Radiotherapy Market to expand their geographic footprints?
  • Which new business models are expected to change the course of growth of key regional markets in near future?
  • Which technologies will witness most attractive research investments and what will be the key sources of funding for startups and new entrants?
  • Which products segments have in recent years have seen new, lucrative application areas?

Why Choose Fact.MR?

  1. Deliver updated information on the current industry trends
  2. Available 24/7 to facilitate clients with unbiased solutions
  3. Embrace digital technologies to offer accurate business ideas
  4. Exhaustive supply chain augmentation analysis
  5. Provide reports strictly according to the requirements of the clients

Explore Fact.MR’s Coverage on the Healthcare Domain: 

Leukocyte Count Testing Market – According to the latest research by Fact.MR, the leukocyte count testing market is set to witness exponential growth with over 7%-8% CAGR during 2021-2031. Increasing bacterial infection with the growing adoption of point of care devices will witness a promising growth outlook for leukocyte count testing in the long run.

At-Home Celiac Testing Market – According to the Latest Research by the Fact.MR The Celiac Testing market is set to gain growth in the forecast period 2021-2031 at a CAGR of 8.0%. The Reason for the growth is The increase in prevalence of Celiac disease globally.

Polysaccharide Hemostatic System Market – According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness a XX% growth during the year 2021-2031.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Olaparib API Market Growth reliant on Capacity Expansion, Regulatory Approvals of Key Drug Candidates

The olaparib API market study currently being conducted by Fact.MR forecasts a relatively high growth trajectory through FY 2021-22, amid accelerating cancer treatment research pace by prominent pharmaceutical giants. The market experienced a blip amidst the COVID-19 pandemic crisis, with data exhibiting a 60% decline in new clinical trials. However, a resurgence is being experienced as supply chains revert to normal, heightening expansion prospects.

According to Fact.MR, the olaparib API market is interspersed with a multitude of investments, including development of drug candidates to capacity expansion initiatives. For instance, global pharmaceutical giant Seqens launched a US$ 35 million specialty production unit at its Villeneuve-la-Garenne site in France in 2020 for this purpose. Additionally, regulatory approvals are playing an imperative role in defining the market’s success.

Request Brochure at https://www.factmr.com/connectus/sample?flag=B&rep_id=5279

Key Takeaways from Fact.MR’s Olaparib API Market Study

  • By indication, breast cancer is likely to attract huge investments, attributed to its high prevalence
  • Pharmaceutical companies to be the primary olaparib API end-users amid constant drug development initiatives
  • US to be a lucrative olaparib API market, attributed to the presence of a robust pharmaceutical research network
  • Recent approvals by the National Institute of Health and Care Excellence for ovarian cancer to stimulate sales in the UK
  • Top-notch pharmaceutical research capacities to bolster German olaparib API market growth prospects
  • France to experience high growth amid planned capacity expansion programs by key pharmaceutical giants
  • China & India to cement their dominance in the global olaparib API market

Olaparib API Market- Prominent Drivers

  • High incidence of prostate, breast and ovarian cancers are stimulating olaparib API market growth
  • Increasing regulatory approvals by relevant authorities is assisting manufacturers in establishing their production units across key regions
  • High presence of contract manufacturers due to the voluminous nature of API products likely to drive market growth

Olaparib API Market- Key Restraints

  • Documented side-effects, including reduction in platelet count and musculoskeletal pain, are limiting uptake
  • Preference for alternative cancer treatments sans medicines is likely to restrain future olaparib API sales

Discover more about the olaparib API market with figures and data tables, along with the table of contents. You will also find detailed market segmentation on https://www.factmr.com/report/5279/olaparib-api-market

Competitive Landscape

According to Fact.MR, the following pharmaceutical players are active in the olaparib API landscape: Pfizer Inc., AstraZeneca Plc, Novartis AG, MSN Laboratories Pvt. Ltd., ALP Pharm Beijing Co. Ltd., ScinoPharm Taiwan Ltd., Transo-Pharm USA LLC., Exelixis Inc. and Alembic Pharmaceuticals Ltd. among others.

Launching new drug formulations, conducting extensive R&D and capacity expansion are some prominent expansion measures adopted by the aforementioned players. In December 2020, AstraZeneca Plc. and MSD’s Lynparza (olaparib) was approved for treatment in Japan for advanced ovarian, prostate and pancreatic cancers. These approvals authorize usage for maintenance treatment post-bevacizumab administration for all three cancers.

In March 2021, Exelixis Inc. collaborated with WuXi Biologics for an exclusive license agreement supporting the continued expansion of Exelixis’ oncology biologics pipeline. The initiative is poised to help the company build out its pipeline behind CABOMETYX® (cabozantinib), its flagship product, along with olaparib APIs.

More Insights on the Olaparib API Market

Fact.MR, in its new offering, brings to fore an unbiased analysis of the global olaparib API market, presenting historical demand data (2016-2020) and forecast statistics for the period, 2021-2031. The study divulges compelling insights on the oaparib API market based on indication (ovarian cancer, breast cancer, pancreatic cancer, prostate cancer and others) and end-user (contract manufacturing organizations (CMOs), contract developers & manufacturing organizations (CDMOs) and pharmaceutical companies) across eight major regions (North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, China, Japan and Middle East & Africa).

Explore Fact.MR’s Coverage on the Healthcare Domain: 

Leukocyte Count Testing Market – According to the latest research by Fact.MR, the leukocyte count testing market is set to witness exponential growth with over 7%-8% CAGR during 2021-2031. Increasing bacterial infection with the growing adoption of point of care devices will witness a promising growth outlook for leukocyte count testing in the long run.

At-Home Celiac Testing Market – According to the Latest Research by the Fact.MR The Celiac Testing market is set to gain growth in the forecast period 2021-2031 at a CAGR of 8.0%. The Reason for the growth is The increase in prevalence of Celiac disease globally.

Polysaccharide Hemostatic System Market – According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness a XX% growth during the year 2021-2031.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Rise In Respiratory Disorders In Developed Countries Is The Major Factor Driving The Growth Of The High Concentration Respiratory Masks Market

250 page market research report by Fact.MR, (Leading business and competitive intelligence provider), analyzing how High Concentration Respiratory Masks Market sales will grow During 2018 to 2028

The recent study by Fact.MR on Demand of High Concentration Respiratory Masks Market offers a 10-year forecast.

The High Concentration Respiratory Masks Sales study analyzes crucial trends that are currently determining the growth of High Concentration Respiratory Masks Market.

This High Concentration Respiratory Masks market outlook report explicates on vital dynamics such as the drivers, restraints and opportunities for key players and competitive analysis of High Concentration Respiratory Masks along with key stakeholders as well as emerging players associated with the manufacturing of product.

The Key trends Analysis of High Concentration Respiratory Masks also provides dynamics that are responsible for influencing the future Sales and Demand of High Concentration Respiratory Masks market over the forecast period..

REQUEST A FREE DEMO OF REPORT –https://www.factmr.com/connectus/sample?flag=B&rep_id=2039

Critical insights enclosed in the report:

  • In-depth assessment of the leading Key players Analysis in High Concentration Respiratory Masks Market
  • The regional analysis of the different market segments and sub-segments
  • Recent mergers, acquisitions, collaborations, partnerships, and R&D activities.
  • SWOT analysis of the prominent players in the High Concentration Respiratory Masks market
  • Y-o-Y revenue growth of High Concentration Respiratory Masks market during the forecast period

The report covers following High Concentration Respiratory Masks Market insights and assessment that are helpful for all participants involved in the High Concentration Respiratory Masks market:

  • Data on recently introduced regulations and their impact on key industries and on demand in High Concentration Respiratory Masks
  • Latest industry Analysis on High Concentration Respiratory Masks Market , with key analysis of market drivers, trends, and influencing factors
  • Key trends Analysis of High Concentration Respiratory Masks market and changing consumer preferences in major industries.
  • Changing High Concentration Respiratory Masks demand and consumption of diverse products
  • Major trends underlining funding by key investors in numerous countries
  • New investment opportunities in diverse technology and product or service types
  • Comprehensive data and Competitive analysis of High Concentration Respiratory Masks major players
  • High Concentration Respiratory Masks  market sales in US will grow at a steady pace, driven by growing consumer confidence and economic recovery
  • High Concentration Respiratory Masks demand forecast in Europe remains stable, as many countries such as UK, France, and Germany focus on boosting growth

High Concentration Respiratory Masks Market: Segmentation

Tentatively, the global high concentration respiratory masks market can be segmented on the basis of product type, end users and geography.

Based on product type, the global high concentration respiratory masks market is segmented as:

  • Re-breather High Concentration Respiratory Masks
  • Non-Rebreather High Concentration Respiratory Masks
  • Partial High Concentration Respiratory Masks

Based on age group, the global high concentration respiratory masks market is segmented as:

  • Adult High Respiratory Concentration Masks
  • Children High Respiratory Concentration Masks

Based on usability, the global high concentration respiratory masks market is segmented as:

  • Disposable High Concentration Respiratory Masks
  • Reusable High Concentration Respiratory Masks

Based on end users, the global high concentration respiratory masks market is segmented as:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Rehab Centers
  • Home-based care

Request Customized Report as Per Your Requirements –https://www.factmr.com/connectus/sample?flag=RC&rep_id=2039

Competitive Landscape Analysis On High Concentration Respiratory Masks Market:

To provide decision-makers with credible insights on their competitive landscape, the High Concentration Respiratory Masks industry research report includes detailed market competitive landscape analysis.

The competitive landscape analysis for High Concentration Respiratory Masks Market includes detailed profiles of Tier 1, Tier 2, and Tier 3 players. The respective market share of High Concentration Respiratory Masks manufacturers is provided so business leaders can understand the market scenario.

List of the Leading Companies Profiled in the High Concentration Respiratory Masks Market are:

Examples of some of the key participants operating in the global high concentration respiratory masks market are Ventlab LLC, Intersurgical Ltd., Fairmont Medical, Bound Tree Medical, Teleflex Medical, Salter Labs, Medline Industries, Inc., AHA Hyperbarics GmbH, Bound Tree Medical and VYAIRE.

A comprehensive estimate on Demand of High Concentration Respiratory Masks market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of High Concentration Respiratory Masks market during the forecast period. Price point comparison by region with global average price is also considered in the study.

Key Question answered in the Survey of Ice Cream Cabinets market Report By Fact.MR :

  • High Concentration Respiratory Masks Company & brand share analysis: Company and brand share analysis on High Concentration Respiratory Masksreveals how much market share is captured by Tier 1, Tier 2, and Tier 3 players
  • Outlook of High Concentration Respiratory Masks Market Historical volume analysis: The industry analysis provides data & insights on historical volume sales of High Concentration Respiratory Masks Market
  • High Concentration Respiratory Masks Category & segment level analysis: Fact.MR’s High Concentration Respiratory Masks market sales outlook offers category and segment level analysis on lucrative and nascent product types. Market players can use this information to identify High Concentration Respiratory Masks sales potential and set sales targets at local, country, and regional level.
  • High Concentration Respiratory Masks Consumption by demographics: The outlook of High Concentration Respiratory Masks market intelligence study provides consumption by demographics analysis so market players can design their product and marketing strategies on the basis of high-value consumers
  • Post COVID consumer spending on High Concentration Respiratory Masks market: The report includes post COVID consumer spending analysis. This information will help business leads understand the shifts in purchasing power and behavior
  • Manufacturing trend analysis of High Concentration Respiratory Masks : Vital information on how market players are aligning their manufacturing strategies with respect to evolving consumer sentiments
  • High Concentration Respiratory Masks market Merger and acquisition activity: Fact.MR’s analysis also includes merger & acquisition activity analysis. High Concentration Respiratory Masksmanufacturers and stakeholders will not only know the recent M&As but also understand its impact on competitive landscape and market share
  • High Concentration Respiratory Masks demand by country: The report forecasts High Concentration Respiratory Masks demand by country giving business leaders the High Concentration Respiratory Masks insights to know fast-growing, stable, and mature markets

Explore Fact.MR’s Coverage on the Healthcare Domain: 

Leukocyte Count Testing Market – According to the latest research by Fact.MR, the leukocyte count testing market is set to witness exponential growth with over 7%-8% CAGR during 2021-2031. Increasing bacterial infection with the growing adoption of point of care devices will witness a promising growth outlook for leukocyte count testing in the long run.

At-Home Celiac Testing Market – According to the Latest Research by the Fact.MR The Celiac Testing market is set to gain growth in the forecast period 2021-2031 at a CAGR of 8.0%. The Reason for the growth is The increase in prevalence of Celiac disease globally.

Polysaccharide Hemostatic System Market – According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness a XX% growth during the year 2021-2031.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Cough Systems Market Growth Pursuant to Rising COPD Burden Worldwide – FactMR

Fact.MR’s ongoing cough systems market study forecasts a positive growth outlook through 2021 and beyond, as the global burden of respiratory disorders continues to accumulate. Gains were especially immense during the peak of the COVID-19 pandemic, as 15% of infected individuals’ required hospitalization and oxygen support, with a further 5% of ICU patients require intubation and ventilation therapies.

According to the study, the ever mushrooming burden of chronic obstructive pulmonary disease (COPD) is the primary driver behind the increasing Cough Systems Demand. The Global Burden of Disease Study published by the World Health Organization estimates that over 250 million cases of COPD were recorded since 2016, with the primary cause being exposure to tobacco smoke, both active and passive. Over 90% of these cases are reported across low and middle-income countries.

Manufacturers are thus finding immense growth opportunities across these regions. South Africa, which has the highest COPD prevalence worldwide (48.9%), is likely to be the most opportunistic market, besides India and China. Players such as Philips Healthcare have a prominent presence, manufacturing its CoughAssist E70 Insufflator-Exsufflator.

Request Brochure at – https://www.factmr.com/connectus/sample?flag=B&rep_id=5277

The global cough systems market is segmented into the device, air delivery mode, end-user and region.

By device, the global cough systems market is further segmented into;

  • The Automatic Cough Assist Device
  • The Manual Cough Assist Device

By air delivery mode, the global cough systems market is further segmented into;

  • Face mask
  • Mouthpiece
  • Adapter
  • Vest

By end-user, the global cough systems market is further segmented into;

  • Hospital
  • Clinic
  • Nursing Home

Key Takeaways from Fact.MR’s Cough Systems Market Study

  • Demand for automatic cough assist devices to soar, owing to higher degree of flexibility
  • By air delivery mode, cough mouthpieces to remain the preferred choice of clinicians
  • Hospitals to be the primary end-users of cough assist devices amid rising demand for specialized patient care
  • US to drive bulk of cough systems sales across North America, owing to high COPD prevalence rates
  • High rates of pneumonia to increase assisted coughing uptake in the UK, widening growth prospects
  • Germany and France to experience high cough systems sales volumes amid increasing efforts to enhance health insurance coverage
  • India & China to emerge as lucrative Asian markets, with high prevalence rates of asthma and tobacco smoking

Cough Systems Market- Prominent Drivers

  • High incidence of tobacco smoking is increasing prevalence rates of respiratory problems, compounding market growth
  • Rising emission levels is leading to high prevalence of COPD and asthma, stimulating demand
  • Manufacturers are foraying into emerging markets such as South Africa, due to the world’s highest COPD prevalence rate

Cough Systems Market- Key Restraints

  • Possibility of oxygen desaturation among sensitive patients likely to restrict uptake of cough system devices
  • Availability of alternate treatments which are non-invasive, such as positive-pressure ventilation (PPV) is likely to restrain uptake

Discover more about the cough systems market with figures and data tables, along with the table of contents. You will also find detailed market segmentation on https://www.factmr.com/report/5277/cough-systems-market

Cough Systems Market: Key players

The key players of the global cough systems market include Koninklijke Philips N.V., Vitality Medical, Oxygen Concentrator Store, Hill-Rom Services, Inc., Electromed, Emerson Electric Co., Ventec Life Systems., United Hayek Industries Inc., Dima Italia Srl, Wellmark Inc. and others.

Competitive Landscape

The aforementioned players rely on a number of expansion strategies- including offering new products and collaborating or acquiring existing manufacturers. United Hayek Industries (Hayek Medical) offers the HRTX Ventilator which provides a non-invasive approach to external ventilation, deploying the Biphasic Cuirass Ventilation (BCV) technique, mostly suited for homecare settings.

Likewise, Vitality Medical offers the Cough Assist T70 Device and T70 Cough Assist Accessories respectively. The Respironics Cough Assist T70 assists with the removal of bronchial secretions, working on the principle of mechanical insufflation and exsufflation, thereby reducing the risk of respiratory complications. It is also equipped with the Cough-Trak feature, enabling treatment synchronization with patient breathing patterns.

More Insights on the Cough Systems Market

Fact.MR, in its new offering, brings to fore an unbiased analysis of the global cough systems market, presenting historical demand data (2016-2020) and forecast statistics for the period, 2021-2031. The study divulges compelling insights on the cough systems market based on device (automatic cough assist device and manual cough assist device), air delivery mode (face mask, mouthpiece, adapter and vest) and end-user (hospitals, clinics and nursing homes) across seven major regions (North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa).

Explore Fact.MR’s Coverage on the Healthcare Domain: 

Leukocyte Count Testing Market – According to the latest research by Fact.MR, the leukocyte count testing market is set to witness exponential growth with over 7%-8% CAGR during 2021-2031. Increasing bacterial infection with the growing adoption of point of care devices will witness a promising growth outlook for leukocyte count testing in the long run.

At-Home Celiac Testing Market – According to the Latest Research by the Fact.MR The Celiac Testing market is set to gain growth in the forecast period 2021-2031 at a CAGR of 8.0%. The Reason for the growth is The increase in prevalence of Celiac disease globally.

Polysaccharide Hemostatic System Market – According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness a XX% growth during the year 2021-2031.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Rising Preference Of Capnometers Over Oximetry Will Also Propel The Growth Of The Capnography Market 2031

According to Fact.MR, Insights of Capnography is a specialized and in-depth study of the industry with a special focus on the Key Trends of Capnography is a Service. The report aims to provide an overview with detailed segmentation by type, application, end use and geography. The global is expected to witness high growth during the forecast period.

A survey offers detailed analysis on key growth drivers of Capnography and trends accelerating Capnography sales globally. The survey also gives detailed analysis on the competitive landscape of Capnography identifying key players and analyzing the impact of their growth strategies.

Request for a Brochure- https://www.factmr.com/connectus/sample?flag=B&rep_id=5275

Tentatively, the global Capnography Market has been segmented on the basis of modality, end-user and region.

Based on technology, the global Capnography Market is segmented as:

  • Main-stream
  • Side-stream
  • Micro-stream

Based on Application, the global Capnography Market is segmented as:

  • Procedural sedation
  • Emergency medicine
  • General floor
  • Pain management
  • Critical care

Based on end-users, the global Capnography Market is segmented as:

  • Hospitals
  • Ambulatory surgical centers
  • Clinics

 Request Customized Report as Per Your Requirements- https://www.factmr.com/connectus/sample?flag=RC&rep_id=5275

Some of the players identified in the Capnography Market include:

  • Medtronic
  • Masimo
  • Drägerwerk AG & Co. KGaA
  • Smiths Medical
  • Becton, Dickinson and Company
  • Koninklijke Philips
  • Nonin
  • CareFusion
  • Welch Allyn

 Key Highlights:-

  • Sales of Capnography In 2020
  • Competitive Analysis Of Capnography
  • Demand Analysis Of Capnography
  • Key Trends Of Supply Side Analysis Of  Capnography
  • Outlook Of Capnography
  • Insights Of  Capnography
  • Analysis Of Capnography
  • Survey Of Capnography
  • Size Of Capnography

A short viewpoint offered in the report elucidates the macro-economic aspects that influence the growth drivers of Capnography which includes global GDP growth rate, various industries growth rate, such as cosmetics, pharmaceuticals, food and others.

This newly published and insightful report compounds sheds light on key dynamics, Key Trends of Capnography and their impact on the overall value chain from suppliers to end-users, which are expected to transform the future of the global Capnography sales.

Why choose Fact.MR?                                         

We carry immense pride in saying that our work is recognized by 150+ countries worldwide. Our experience is conveyed by the fact that we have published 6, 000+ reports, thanks to our dedicated team of professionals. With digital intelligence solutions, we support our clients in remaining at the driver’s seat. Our crew of 300+ analysts are available 24/7 to offer dynamic updates regarding various verticals and companies.

Explore Fact.MR’s Coverage on the Healthcare Domain: 

Leukocyte Count Testing Market – According to the latest research by Fact.MR, the leukocyte count testing market is set to witness exponential growth with over 7%-8% CAGR during 2021-2031. Increasing bacterial infection with the growing adoption of point of care devices will witness a promising growth outlook for leukocyte count testing in the long run.

At-Home Celiac Testing Market – According to the Latest Research by the Fact.MR The Celiac Testing market is set to gain growth in the forecast period 2021-2031 at a CAGR of 8.0%. The Reason for the growth is The increase in prevalence of Celiac disease globally.

Polysaccharide Hemostatic System Market – According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness a XX% growth during the year 2021-2031.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Global Dexamethasone Market Is Expected To Grow By 46.9 USD Billion By 2027

Fact.MR has adopted multi-disciplinary approach to shed light on the evolution of the Dexamethasone Market during the historical period. The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year of 2019, and key prospects over the forecast period 2020 to 2030. Extensive rounds of primary and a comprehensive secondary research have been leveraged by the analysts at Fact.MR to arrive at various estimations and projections of the Dexamethasone Market, both at global and regional levels. The analysts have used numerous industry-wide prominent business intelligence tools to consolidate facts, figures, and market data into revenue estimations and projections in the market. The segment accounted for a promising share in the Dexamethasone Market in 2020 to 2030. The share in this segment comes with a wide range of opportunities including manufacturing products, distribution, retail, and marketing services.

Key stakeholders in the Dexamethasone Market including industry players, policymakers, and investors in various countries have been continuously realigning their strategies and approaches to implement them in order to tap into new opportunities. Many in recent months have overhauled their strategies to remain agile in the backdrop of worldwide disruptions caused by the COVID-19 pandemic.

Request for Brochure – https://www.factmr.com/connectus/sample?flag=B&rep_id=5271

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa, Rest of MEA)

Dexamethasone market: Segmentation

The global Dexamethasone market is segmented based on the type of route of administration, application, distribution channels and region.

By route of administration dexamethasone market is segmented as:

  • Nasal
  • Ophthalmic
  • Otic
  • Topical
  • Oral
  • Injectable

By application dexamethasone market is segmented as:

  • Rheumatoid arthritis
  • Psoriasis
  • Eczema
  • Pulmonary diseases
  • COVID-19

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Dexamethasone Key Market players:

The key participants operating in the Dexamethasone market are Allergan plc, Alcon, Pfizer Inc, Morepan laboratories Ltd , Zydus Cadila, Aspen, Cadila Pharmaceuticals, GLS Pharma Ltd, Hikma Pharmaceuticals PLC, Merck and Co, Inc., Xspire Pharma, LLC,  Taro Pharmaceutical Industries Ltd, Pragma Pharmaceuticals, LLC,  Trotwood Pharma Limited, Wellona pharma, Wokhardt, Sandoz AG and AdvaCare Pharma.

Get Customized Research – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5271

Why Choose Fact.MR?

  1. Deliver updated information on the current industry trends
  2. Available 24/7 to facilitate clients with unbiased solutions
  3. Embrace digital technologies to offer accurate business ideas
  4. Exhaustive supply chain augmentation analysis
  5. Provide reports strictly according to the requirements of the clients

What insights readers can gather from the Dexamethasone Market report?

  • Learn the strategies, and modus operandi of every Dexamethasone Market player –expansions, product launches, collaborations and acquisitions in the market currently
  • Enter the market with an objective view of of the progress outlook of the global Dexamethasone landscape, including total revenue, consumption and production, and historical & forecast 2020 to 2030
  • Get your hands on key drivers, opportunities, challenges to growth and trends (DROT Analysis)
  • Get a sneak-peek of trends, R&D developments, such as carbon footprint, prototype technologies, and globalization

The Dexamethasone Market report answers the following queries:

    1. What is the largest share held by key players in the market?
    2. What strategies have proven most advantageous in the Dexamethasone Market?
    3. Which region promises largest opportunity for new investors during the forecast period 2020 to 2030?
    4. What factors will most likely present challenges to growth during the forecast period?
  1. What will be the value of total revenues, and at what CAGR will the growth compound during the forecast period 2020 to 2030?

Explore Fact.MR’s Coverage on the Healthcare Domain: 

Leukocyte Count Testing Market – According to the latest research by Fact.MR, the leukocyte count testing market is set to witness exponential growth with over 7%-8% CAGR during 2021-2031. Increasing bacterial infection with the growing adoption of point of care devices will witness a promising growth outlook for leukocyte count testing in the long run.

At-Home Celiac Testing Market – According to the Latest Research by the Fact.MR The Celiac Testing market is set to gain growth in the forecast period 2021-2031 at a CAGR of 8.0%. The Reason for the growth is The increase in prevalence of Celiac disease globally.

Polysaccharide Hemostatic System Market – According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness a XX% growth during the year 2021-2031.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com